Ehrlich, Lori A <br/><br/>
IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma.  [electronic resource] 

 -  Blood  Aug 2005 
 - 1407-14 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2005-03-1080  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Bone Marrow Cells--pathology<br/>Cell Differentiation--drug effects<br/>Cell Line, Tumor<br/>Cells, Cultured<br/>Hematopoietic Stem Cells<br/>Humans<br/>Interleukin-3--pharmacology<br/>Leukocyte Common Antigens<br/>Mice<br/>Multiple Myeloma--drug therapy<br/>Osteoblasts--drug effects<br/>Osteoclasts--drug effects<br/>Stromal Cells--pathology